Healthcare Triangle financials
$0.6615−11.76%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.2M | $9.9M | $3.1M | $3.5M | $3.6M | $3.7M | $2.2M | $2.4M | $3.0M | $4.1M | $7.1M | $7.8M |
| Gross profit | $2.1M | $2.4M | $448.0K | $618.0K | $494.0K | $329.0K | $256.0K | $722.0K | $898.0K | $1.0M | $1.5M | $1.7M |
| Gross margin | 22.5% | 24.3% | 14.3% | 17.7% | 13.9% | 8.9% | 11.7% | 29.9% | 30.1% | 24.7% | 21.7% | 21.9% |
| Operating income | -$4.1M | -$3.6M | -$4.4M | -$2.6M | -$1.4M | -$1.4M | -$498.0K | -$1.2M | -$1.4M | -$1.7M | -$1.4M | -$1.5M |
| Net income | -$4.4M | -$6.2M | -$4.5M | -$1.9M | -$1.4M | -$1.7M | -$1.3M | -$1.2M | -$1.5M | -$1.9M | -$1.7M | -$1.9M |
| Net margin | −47.7% | −62.9% | −143.1% | −54.6% | −38.4% | −45.9% | −61.6% | −51.8% | −50.6% | −45.3% | −23.8% | −25.0% |
| Diluted EPS | $-1.56 | $-6.66 | — | $-25.20 | $-35.01 | $-0.17 | $-1212.19 | $-3293.40 | $-4243.20 | $-6274.80 | $-6283.21 | $-6723.00 |
| EBITDA | -$3.5M | -$2.8M | -$3.8M | -$2.5M | -$1.4M | -$1.4M | -$643.0K | -$824.0K | -$1.2M | -$1.2M | -$479.0K | -$810.0K |
| Operating cash flow | -$833.0K | -$6.9M | -$6.8M | -$1.5M | -$2.6M | -$5.6M | -$811.0K | $715.0K | -$935.0K | -$50.0K | $599.0K | $0.00 |
| Free cash flow | -$861.0K | -$6.9M | -$7.1M | -$1.5M | -$3.2M | -$5.6M | -$811.0K | $715.0K | -$935.0K | -$50.0K | $594.0K | -$5.0K |
| Diluted shares | 2.8M | 0.9M | — | 0.1M | 0.0M | 9.8M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.9M | $4.3M | $7.6M | $1.6M | $3.2M | $6.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $11.8M | $9.7M | $10.7M | $1.5M | $415.0K | $775.0K |
| Total assets | $73.6M | $80.2M | $22.7M | $13.8M | $14.6M | $11.8M |
| Total liabilities | $24.5M | $27.5M | $12.8M | $5.1M | $4.4M | $3.2M |
| Shareholders' equity | $49.1M | $52.7M | $9.9M | $8.7M | $10.2M | $8.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology